Jim Meyers

Jim Meyers has extensive work experience in the pharmaceutical and biotech industry. Jim is currently serving as the President & CEO of IntraBio Ltd. Since 2020. Prior to this, they worked as a Senior Advisor at the Boston Consulting Group (BCG) starting in 2019. Jim also served as a Board Member for Sangamo Therapeutics, Inc., CytomX Therapeutics, Arbutus Biopharma Corporation, and Pulmocide. Additionally, Jim Meyers has held various senior positions at Gilead Sciences, including Executive Vice President of the Worldwide Commercial Organization. Jim also worked at Astra Pharmaceuticals and Stuart Pharmaceuticals, where they gained experience in sales, training, and sales management.

Jim Meyers attended Boston College from 1982 to 1986, where they earned a Bachelor's degree in Economics.